Viste A, Perry KI, Taunton MJ et al (2017) Proximal femoral replacement in contemporary revision total hip arthroplasty for severe femoral bone loss: a review of outcomes. Bone Jt J 99-B:325–329. https://doi.org/10.1302/0301-620X.99B3.BJJ-2016-0822.R1
Grammatopoulos G, Alvand A, Martin H et al (2016) Five-year outcome of proximal femoral endoprosthetic arthroplasty for non-tumour indications. Bone Jt J 98-B:1463–1470. https://doi.org/10.1302/0301-620X.98B11.BJJ-2016-0244.R1
De Martino I, D’Apolito R, Nocon AA et al (2018) Proximal femoral replacement in non-oncologic patients undergoing revision total hip arthroplasty. Int Orthop. https://doi.org/10.1007/s00264-018-4220-4
Capanna R, Scoccianti G, Frenos F et al (2015) What was the survival of megaprostheses in lower limb reconstructions after tumor resections? Clin Orthop 473:820–830. https://doi.org/10.1007/s11999-014-3736-1
Gusho CA, Clayton B, Mehta N et al (2021) Survival and outcomes of modular endoprosthetic reconstruction of the proximal femur for primary and non-primary bone tumors: Single institutional results. J Orthop 25:145–150. https://doi.org/10.1016/j.jor.2021.05.008
Article PubMed PubMed Central Google Scholar
Yilmaz M, Sørensen MS, Saebye C et al (2019) Long-term results of the Global Modular Replacement System tumor prosthesis for reconstruction after limb-sparing bone resections in orthopedic oncologic conditions: Results from a national cohort. J Surg Oncol 120:183–192. https://doi.org/10.1002/jso.25490
Henderson ER, O’Connor MI, Ruggieri P et al (2014) Classification of failure of limb salvage after reconstructive surgery for bone tumours. Bone Jt J 96-B:1436–1440. https://doi.org/10.1302/0301-620X.96B11.34747
Enneking WF, Dunham W, Gebhardt MC et al (1993) A system for the functional evaluation of reconstructive procedures after surgical treatment of tumors of the musculoskeletal system. Clin Orthop 286:241–246
Mallet J, El Kinani M, Crenn V et al (2023) French translation and validation of the cross-cultural adaptation of the MSTS functional assessment questionnaire completed after tumor surgery. Orthop Traumatol Surg Res 109:103574. https://doi.org/10.1016/j.otsr.2023.103574
Fine JP, Gray RJ (1999) A proportional hazards model for the subdistribution of a competing risk. J Am Stat Assoc 94:496–509. https://doi.org/10.2307/2670170
Toepfer A, Straßer V, Ladurner A et al (2021) Different outcomes after proximal femoral replacement in oncologic and failed revision arthroplasty patients - a retrospective cohort study. BMC Musculoskelet Disord 22:813. https://doi.org/10.1186/s12891-021-04673-z
Article PubMed PubMed Central Google Scholar
Staats K, Vertesich K, Sigmund IK et al (2020) Does a competing risk analysis show differences in the cumulative incidence of revision surgery between patients with oncologic and non-oncologic conditions after distal femur replacement? Clin Orthop 478:1062–1073. https://doi.org/10.1097/CORR.0000000000001106
Lari A, Esmaeil A, AlSalem Y et al (2024) Comparative outcomes and failure rates of total femur replacement in oncologic and nononcologic indications. Jbjs Rev 12(e24):00022. https://doi.org/10.2106/JBJS.RVW.24.00022
Janssen SJ, van Rein EAJ, Paulino Pereira NR et al (2016) The discrepancy between patient and clinician reported function in extremity bone metastases. Sarcoma 2016:e1014248. https://doi.org/10.1155/2016/1014248
Colman M, Choi L, Chen A et al (2014) Proximal femoral replacement in the management of acute periprosthetic fractures of the hip: a competing risks survival analysis. J Arthroplasty 29:422–427. https://doi.org/10.1016/j.arth.2013.06.009
Khajuria A, Ward J, Cooper G et al (2018) Is endoprosthetic replacement of the proximal femur appropriate in the comorbid patient? Hip Int J Clin Exp Res Hip Pathol Ther 28:68–73. https://doi.org/10.5301/hipint.5000520
Varenne Y, Corvec S, Leroy A-G et al (2021) A short-course antibiotic prophylaxis is associated with limited antibiotic resistance emergence in post-operative infection of pelvic primary bone tumor resection. Antibiot Basel Switz 10:768. https://doi.org/10.3390/antibiotics10070768
Döring K, Vertesich K, Martelanz L et al (2021) Proximal femoral reconstruction with modular megaprostheses in non-oncological patients. Int Orthop. https://doi.org/10.1007/s00264-021-05080-8
Abdel MP, Watts CD, Houdek MT et al (2016) Epidemiology of periprosthetic fracture of the femur in 32 644 primary total hip arthroplasties: a 40-year experience. Bone Jt J 98-B:461–467. https://doi.org/10.1302/0301-620X.98B4.37201
Kuitunen I, Ponkilainen VT, Uimonen MM et al (2021) Testing the proportional hazards assumption in cox regression and dealing with possible non-proportionality in total joint arthroplasty research: methodological perspectives and review. BMC Musculoskelet Disord 22:489. https://doi.org/10.1186/s12891-021-04379-2
Article PubMed PubMed Central Google Scholar
Biau DJ, Latouche A, Porcher R (2007) Competing events influence estimated survival probability: when is Kaplan-Meier analysis appropriate? Clin Orthop 462:229–233. https://doi.org/10.1097/BLO.0b013e3180986753
Maradit Kremers H, Devick KL, Larson DR et al (2021) Competing risk analysis: what does it mean and when do we need it in orthopedics research? J Arthroplasty 36:3362–3366. https://doi.org/10.1016/j.arth.2021.04.015
Schuster NA, Hoogendijk EO, Kok AAL et al (2020) Ignoring competing events in the analysis of survival data may lead to biased results: a nonmathematical illustration of competing risk analysis. J Clin Epidemiol 122:42–48. https://doi.org/10.1016/j.jclinepi.2020.03.004
Smolle MA, Friesenbichler J, Bergovec M et al (2020) How is the outcome of the Limb Preservation System™ for reconstruction of hip and knee? Orthop Traumatol Surg Res OTSR 106:409–415. https://doi.org/10.1016/j.otsr.2019.09.030
Puchner SE, Funovics PT, Böhler C et al (2017) Oncological and surgical outcome after treatment of pelvic sarcomas. PLoS ONE 12:e0172203. https://doi.org/10.1371/journal.pone.0172203
Article CAS PubMed PubMed Central Google Scholar
Schuh R, Kaider A, Windhager R, Funovics PT (2015) Does competing risk analysis give useful information about endoprosthetic survival in extremity osteosarcoma? Clin Orthop 473:900–906. https://doi.org/10.1007/s11999-014-3703-x
Berger C, Larsson S, Bergh P et al (2021) The risk for complications and reoperations with the use of mega prostheses in bone reconstructions. J Orthop Surg 16:598. https://doi.org/10.1186/s13018-021-02749-z
Prophylactic Antibiotic Regimens in Tumor Surgery (PARITY) Investigators, Ghert M, Schneider P et al (2022) Comparison of prophylactic intravenous antibiotic regimens after endoprosthetic reconstruction for lower extremity bone tumors: a randomized clinical trial. JAMA Oncol 8:345–353. https://doi.org/10.1001/jamaoncol.2021.6628
Crenn V, Briand S, Rosset P et al (2019) Clinical and dynamometric results of hip abductor system repair by trochanteric hydroxyapatite plate with modular implant after resection of proximal femoral tumors. Orthop Traumatol Surg Res OTSR 105:1319–1325. https://doi.org/10.1016/j.otsr.2019.08.011
García-Rey E, García-Cimbrelo E (2016) Abductor biomechanics clinically impact the total hip arthroplasty dislocation rate: a prospective long-term study. J Arthroplasty 31:484–490. https://doi.org/10.1016/j.arth.2015.09.039
Hamadouche M, Ropars M, Rodaix C et al (2017) Five to thirteen year results of a cemented dual mobility socket to treat recurrent dislocation. Int Orthop 41:513–519. https://doi.org/10.1007/s00264-016-3343-8
Viste A, Desmarchelier R, Fessy M-H (2017) Dual mobility cups in revision total hip arthroplasty. Int Orthop 41:535–542. https://doi.org/10.1007/s00264-016-3363-4
留言 (0)